undecylamine hydrochloride | 2016-37-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: undecylamine hydrochloride
• 英文别名: Undecylam-monium chloride；undecylazanium;chloride
• CAS: 2016-37-7
• 化学式: C₁₁H₂₅N*ClH
• 分子量: 207.787
• InChiKey: ZQQKMLSWWANXNO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  13
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  undecylamine hydrochloride 、 sodium dicyanamide 以 异丙醇 为溶剂， 生成 N1-undecyl-N'-cyanoguanidine
  参考文献：
  名称：

  Synthesis of Novel 4,6-Di(substituted)amino-1,2-dihydro-1,3,5-triazine Derivatives as Topical Antiseptic Agents

  摘要：

  A series of novel 4,6-di(substituted)amino-1,2-dihydro-1,3,5-triazine derivatives designed to have ClogP of 5.1-7.5 was synthesized and evaluated for their antiseptic properties by MIC and MBC tests against Gram-positive and Gram-negative bacteria, including MRSA, VRE, and P. aeruginosa. Among these compounds, 4-alkyl-6-aralkyl derivatives having ClogP of 6.6-7.1 and 4-alkyl-6-aryl or 4,6-dialkyl derivatives with ClogP of 6.0-6.4 showed pronounced antibacterial activities in both tests.

  DOI：

  10.1021/jm8014712
• 作为产物：
  描述：

  氯乙酸 以60%的产率得到
  参考文献：
  名称：

  LIMANOV V. E.; IVANOV S. B.; SUKIASYAN A. N.; SKVORTSOVA E. K., XIM.-FARMATS. ZH., 1981, 15, HO 6, 35-39

  摘要：

  DOI：

文献信息

• [EN] NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF<br/>[FR] NOUVEAUX ANTAGONISTES DE LA GLUTAMINE ET LEURS UTILISATIONS
  申请人：UNIV JOHNS HOPKINS

  公开号：WO2019071110A1

  公开（公告）日：2019-04-11

  Glutamine antagonists and their use for treating oncological, immunological, and neurological diseases are disclosed. Also disclosed are methods for treating an oncological, immunological, infectious or neurological disease or disorder, the method comprising administering to a subject in need of treatment thereof a therapeutically effective amount of a glutamine antagonist of the disclosure or the pharmaceutical composition thereof. Also disclosed are methods of enhancing the effects of an immune checkpoint inhibitor, enabling a subject to respond to an immune checkpoint inhibitor, or enabling the toxicity or the dose or number of treatments with an immune checkpoint inhibitor to be reduced, comprising administering to a subject in need of treatment thereof a therapeutically effective amount of a glutamine antagonist of the disclosure or the pharmaceutical composition thereof, and an immune checkpoint inhibitor. Also disclosed are methods for treating an oncological, immunological, infectious or neurological disease or disorder that is refractory to checkpoint inhibitor therapy, the method comprising administering to a subject in need thereof, and having the refractory disease or disorder, a therapeutically effective amount of a glutamine antagonist of the disclosure or the pharmaceutical composition thereof.

  谷氨酰胺拮抗剂及其用于治疗肿瘤、免疫和神经系统疾病的方法已被披露。还披露了治疗肿瘤、免疫、传染性或神经系统疾病或紊乱的方法，该方法包括向需要治疗的受试者施用本公开的谷氨酰胺拮抗剂或其药物组成的治疗有效量。还披露了增强免疫检查点抑制剂效果的方法，使受试者对免疫检查点抑制剂产生反应，或减少免疫检查点抑制剂的毒性或剂量或治疗次数的方法，包括向需要治疗的受试者施用本公开的谷氨酰胺拮抗剂或其药物组成的治疗有效量，以及免疫检查点抑制剂。还披露了治疗对检查点抑制剂疗法无效的肿瘤、免疫、传染性或神经系统疾病或紊乱的方法，该方法包括向需要治疗的受试者施用本公开的谷氨酰胺拮抗剂或其药物组成的治疗有效量。
• [EN] NOVEL METHOD FOR SYNTHESIZING DEUTERATED AMIDES AND DEUTERATED SULFONAMIDES<br/>[FR] NOUVEAU PROCÉDÉ DE SYNTHÈSE D'AMIDES DEUTÉRÉS ET DE SULFONAMIDES DEUTÉRÉS<br/>[ZH] 一种合成氘代酰胺及氘代磺酰胺的新方法
  申请人：HINOVA PHARMACEUTICALS INC

  公开号：WO2019196945A1

  公开（公告）日：2019-10-17

  公开了一种合成氘代酰胺及氘代磺酰胺的新方法，步骤如下：(1)将化合物M、DMAP、R 3-X加入到溶剂中，反应完全后得化合物N；(2)将化合物N、R 4-NH-R 5或其盐、碱加入到溶剂中，反应完全后，纯化得化合物Ⅰ。该方法反应条件温和，路线短，仅需两步即可得到，可以应用于已有方法不能适用的原料，提高合成效率，可以适用于很多酰胺类化合物，具有较强的普适性，为制备氘代胺的酰胺及磺酰胺类化合物提供了一种新的选择。
• Olefin polymerisation catalysts and processes for producing olefin polymers
  申请人：TOSOH CORPORATION

  公开号：EP0849292A1

  公开（公告）日：1998-06-24

  Catalysts for olefin polymerization which consist essentially of a transition metal compound, a modified clay compound and an organic aluminum compound, wherein the modified clay compound comprises a reaction product of a clay mineral and a proton acid salt of a specific amine compound, as well as a method of polymerizing olefins using such catalysts. It is possible thereby to obtain olefin polymers with high productivity and low ash content.

  烯烃聚合催化剂，主要由过渡金属化合物、改性粘土化合物和有机铝化合物组成，其中改性粘土化合物包括粘土矿物和特定胺化合物的质子酸盐的反应产物，以及使用这种催化剂聚合烯烃的方法。由此可以获得生产率高、灰分含量低的烯烃聚合物。
• Prodrugs of glutamine analogs
  申请人：THE JOHNS HOPKINS UNIVERSITY

  公开号：US10336778B2

  公开（公告）日：2019-07-02

  The disclosure provides compounds having formula (I): and the pharmaceutically acceptable salts thereof, wherein R1, R2, R2′, and X are as defined as set forth in the specification. Compounds having formula (I) are prodrugs that release glutamine analogs, e.g., 6-diazo-5-oxo-L-norleucine (DON). The disclosure also provides compounds having formula (I) for use in treating cancer.

  本公开提供了具有式 (I) 的化合物： 及其药学上可接受的盐，其中R1、R2、R2′和X如说明书中所定义。具有式（I）的化合物是释放谷氨酰胺类似物的原药，例如 6-重氮-5-氧代-L-正亮氨酸（DON）。本公开还提供了用于治疗癌症的具有式（I）的化合物。
• Cobalamin compounds useful as antibiotic agents and as imaging agents
  申请人：——

  公开号：US20020042394A1

  公开（公告）日：2002-04-11

  The invention provides cobalamin derivatives linked to an antibiotic and/or an imaging agent, as well as pharmaceutical compositions comprising the compounds and methods for using the compounds in treatment or diagnosis of a microbial infection.

  本发明提供了与抗生素和/或成像剂连接的钴胺衍生物，以及包含这些化合物的药物组合物和使用这些化合物治疗或诊断微生物感染的方法。